Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice

Physiological Genomics

Volumn 2000, Issue 3, 2000, Pages 133-144

  Ebihara, Satoru ^a   Guibinga, Ghiabe Henri ^a   Gilbert, Renald ^b   Nalbantoglu, Josephine ^b   Massie, Bernard ^c   Karpati, George ^b   Petrof, Basil J ^a,b,d  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^d ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Duchenne Becker muscular dystrophy; Gene therapy; Host immunity; Muscle mechanics; Viral vectors

Indexed keywords

CYTOSKELETON PROTEIN; DYSTROPHIN; MEMBRANE PROTEIN; RECOMBINANT DNA; UTRN PROTEIN, MOUSE; UTROPHIN;

ADENOVIRUS; ANIMAL; ANIMAL MUSCULAR DYSTROPHY; ARTICLE; CHEMISTRY; DUCHENNE MUSCULAR DYSTROPHY; GENE THERAPY; GENE TRANSFER; GENETICS; HINDLIMB; IMMUNOCOMPETENCE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MECHANICAL STRESS; METABOLISM; MOUSE; MUSCLE; MUSCLE CONTRACTION; NEWBORN; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ADENOVIRIDAE; ANIMALS; ANIMALS, NEWBORN; CYTOSKELETAL PROTEINS; DNA, RECOMBINANT; DYSTROPHIN; GENE THERAPY; GENE TRANSFER TECHNIQUES; HINDLIMB; IMMUNOCOMPETENCE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MEMBRANE PROTEINS; MICE; MICE, INBRED MDX; MUSCLE CONTRACTION; MUSCLES; MUSCULAR DYSTROPHY, ANIMAL; MUSCULAR DYSTROPHY, DUCHENNE; STRESS, MECHANICAL; UTROPHIN;

EID: 0034622814     PISSN: 15312267     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Acsadi G, Lochmuller H, Jani A, Huard J, Massie B, Prescott S, Simoneau M, Petrof BJ, and Karpati G. Dystrophin expression in muscles of mdx mice after adenovirus-mediated in vivo gene transfer. Hum Gene Ther 7: 129-140, 1996.
2. Anderson JE, Ovalle WK, and Bressler BH. Electron microscopic and autoradiographic characterization of hindlimb muscle regeneration in the mdx mouse. Anat Rec 219: 243-257, 1987.
3. Billingham RE, Brent L, and Medawar PB. "Actively acquired tolerance" of foreign cells. Nature 172: 603-606, 1953.
4. Bittner RE, Shorny S, Streubel B, Hubner C, Voit T, and Kress W. Serum antibodies to the deleted dystrophin sequence after cardiac transplantation in a patient with Becker's muscular dystrophy. N Engl J Med 333: 732-733, 1995.
5. Chen HH, Mack LM, Choi SY, Ontell M, Kochanek S, and Clemens PR. DNA from both high-capacity and first-generation adenoviral vectors remains intact in skeletal muscle. Hum Gene Ther 10: 365-373, 1999.
6. Deconinck AE, Rafael JA, Skinner JA, Brown SC, Potter AC, Metzinger L, Watt DJ, Dickson G, Tinsley JM, and Davies KE. Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell 90: 717-727, 1997.
7. Deconnick N, Tinsley J, De Backer F, Fisher R, Kahn D, Phelps S, Davies K, and Gillis JM. Expression of truncated utrophin leads to major functional improvement in dystrophin-deficient muscles of mice. Nat Med 3: 1216-1221, 1997.
8. Gilbert R, Nalbantoglu J, Petrof BJ, Ebihara S, Guibinga GH, Tinsley JM, Kamen A, Massie B, Davies KE, and Karpati G. Adenovirus-mediated utrophin gene transfer mitigates the dystrophic phenotype of mdx mouse muscles. Hum Gene Ther 10: 1299-1310, 1999.
9. Gilbert R, Nalbantoglu J, Tinsley JM, Massie B, Davies KE, and Karpati G. Efficient utrophin expression following adenovirus gene transfer in dystrophic muscles. Biochem Biophys Res Commun 242: 244-247, 1998.
10. Grady RM, Teng H, Nichol MC, Cunningham JC, Wilkinson RS, and Sanes JR. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell 90: 729-738, 1997.
11. Guibinga GH, Lochmüller H, Massie B, Nalbantoglu J, Karpati G, and Petrof BJ. Combinatorial blockade of calcineurin and CD28 signaling facilitates primary and secondary therapeutic gene transfer by adenovirus vectors in dystrophic (mdx) mouse muscles. J Virol 72: 4601-4609, 1998.
12. Gussoni E, Soneoka Y, Strickland CDBEA, Khan MA, Kunkel LM, and Mulligan RC. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401: 390-394, 2000.
13. Haecker SE, Stedman HH, Balice-Gordon RJ, Smith DBJ, Greelish JP, Mitchell MA, Wells A, Sweeney HL, and Wil-son JM. In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes. Hum Gene Ther 7: 1907-1914, 1996.
14. Harms JS and Splitter GA. Interferon-γ inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter. Hum Gene Ther 6: 1291-1297, 1995.
15. Helliwell TR, Man NT, Morris GE, and Davies KE. The dystrophin-related protein, utrophin, is expressed on the sarcolemma of regenerating human skeletal muscle fibres in dystrophies and inflammatory myopathies. Neuromuscul Disord 2: 177-184, 1992.
16. Hoffman EP, Brown RHJ, and Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51: 919-928, 1987.
17. Hoffman EP, Morgan JE, Watkins SC, and Partridge TA. Somatic reversion/suppression of the mouse mdx phenotype in vivo. J Neurol Sci 99: 9-25, 1990.
18. Holt KH, Lim LE, Straub V, Venzke DP, Duclos F, Anderson RD, Davidson BL, and Campbell KP. Functional rescue of the sarcoglycan complex in the BIO 14.6 hamster using δ-sarcoglycan gene transfer. Mol Cell 1: 841-848, 1998.
19. Ibraghimov Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, and Campbell KP. Primary structure of dystrophin-associated glycoproteins linking dystro-phin to the extracellular matrix. Nature 355: 696-702, 1992.
20. Karpati G, Carpenter S, Morris GE, Davies KE, Guerin C, and Holland P. Localization and quantitation of the chromosome 6-encoded dystrophin-related protein in normal and pathological human muscle. J Neuropathol Exp Neurol 52: 119-128, 1993.
21. Khurana TS, Watkins SC, Chafey P, Chelly J, Tomé FMS, Fardeau M, Kaplan JC, and Kunkel LM. Immunolocalization and developmental expression of dystrophin related protein in skeletal muscle. Neuromuscul Disord 1: 185-194, 1991.
22. Lochmüller H, Huard AJJ, Prescott S, Simoneau M, Massie B, Karpati G, and Acsadi G. Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants during multiple passages in 293 cells. Hum Gene Ther 5: 1485-1491, 1994.
23. Man NT, Ellis JM, Love DR, Davies KE, Gatter KC, Dickson G, and Morris GE. Localization of the DMDL gene-encoded dystrophin-related protein using a panel of nineteen monoclonal antibodies: presence at neuromuscular junctions, in the sarcolemma of dystrophic skeletal muscle, in vascular and other smooth muscles, and in proliferating brain cell lines. J Cell Biol 115: 1695-1700, 1991.
24. McArdle A, Edwards RHT, and Jackson MJ. Time course of changes in plasma membrane permeability in the dystrophin-deflcient mdx mouse. Muscle Nerve 17: 1378-1384, 1994.
25. Morishita R, Sugimoto T, Aoki M, Kida I, Tomita N, Moriguchi A, Maeda K, Sawa Y, Kaneda Y, Higaki J, and Ogihara T. In vivo transfection of cis element "decoy" against NFKB binding site prevented myocardial infarction as gene therapy. Nat Med 3: 894-899, 1997.
26. Morral N, O'Neal W, Zhou H, Langston C, and Beaudet A. Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors: comparison of E2a wild type and E2a deleted vectors. Hum Gene Ther 8: 1275-1286, 1997.
27. Muruve DA, Barnes MJ, Stillman IE, and Liberman TA. Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo. Hum Gene Ther 10: 965-976, 1999.
28. Ohtsuka Y, Udaka K, Yamashiro Y, Yagita H, and Okumura K. Dystrophin acts as a transplantation rejection antigen in dystrophin-deficient mice: implication for gene therapy. J Immunol 160: 4635-4640, 1998.
29. Petrof BJ, Acsadi G, Jani A, Massie B, Bourdon J, Matusiewicz N, Yang L, Lochmuller H, and Karpati G. Efficiency and functional consequences of adenovirus-mediated in vivo gene transfer to normal and dystrophic (mdx) mouse diaphragm. Am J Respir Cell Mol Biol 13: 508-517, 1995.
30. + T cell deficiency. Hum Gene Ther 7: 1813-1826, 1996.
31. Petrof BJ, Shrager JB, Stedman HH, Kelly AM, and Sweeney HL. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci USA 90: 3710-3714, 1993.
32. Rafael JA, Sunada Y, Cole NM, Campbell KP, Faulkner JA, and Chamberlain JS. Prevention of dystrophic pathology in mdx mice by a truncated dystrophin isoform. Hum Mol Genet 3: 1725-1733, 1994.
33. Stedman HH, Sweeney HL, Shrager JB, Maguire HC, Panettieri RA, Petrof B, Narusawa M, Leferovich JM, Sladky JT, and Kelly AM. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 352: 536-539, 1991.
34. Thorne PS, McCray PB, Howe TS, and O'Neill MA. Early-onset inflammatory responses in vivo to adenoviral vectors in the presence or absence of lipopolysaccharide-induced inflammation. Am J Respir Cell Mol Biol 20: 1155-1164, 1999.
35. Tidball JG. Energy stored and dissipated in skeletal muscle basement membranes during sinusoidal oscillations. Biophys J 50: 1127-1138, 1986.
36. Tinsley JM, Potter AC, Phelps SR, Fisher R, Trickett JI, and Davies KE. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature 384: 349-353, 1996.
37. Tripathy SK, Black HB, Goldwasser E, and Leiden JM. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat Med 2: 545-550, 1996.
38. Vilquin JT, Guérette B, Kinoshita I, Roy B, Goulet M, Gravel C, Roy R, and Tremblay JP. FK506 immunosuppression to control the immune reactions triggered by first-generation adenovirus-mediated gene transfer. Hum Gene Ther 6: 1391-1401, 1995.
39. Vilquin JT, Wagner E, Kinoshita I, Roy R, and Tremblay JP. Successful histocompatible transplantation in dystrophindeficient mdx mouse despite the production of antibodies against dystrophin. J Cell Biol 131: 975-988, 1995.
40. Warren GL, Hayes DA, Lowe DA, and Armstrong RB. Mechanical factors in the initiation of eccentric contraction-induced injury in rat soleus muscle. J Physiol (Lond) 464: 457-475, 1993.
41. Wilcox P, Osborne S, and Bressler B. Monocyte inflammatory mediators impair in vitro hamster diaphragm contractility. Am Rev Respir Dis 146: 462-466, 1992.
42. 2-terminal F-actin binding domain of utrophin. FEBS Lett 357: 125-128, 1995.
43. Worton R. Muscular dystrophies: diseases of the dystrophin-glycoprotein complex. Science 270: 755-756, 1995.
44. Yang L, Lochmüller H, Luo J, Massie B, Nalbantoglu J, Karpati G, and Petrof BJ. Adenovirus-mediated dystrophin minigene transfer improves muscle strength in adult dystrophic (mdx) mice. Gene Ther 5: 369-379, 1998.
45. Yang Y, Haecker SE, Su Q, and Wilson JM. Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle. Hum Mol Genet 5: 1703-1712, 1996.
46. Yang Y, Nunes FA, Berencsi K, Furth EE, Gonczol E, and Wilson JM. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 91: 4407-4411, 1994.